ArticleBMC infectious diseases2025
Genetic characteristics and epidemiology of influenza and respiratory syncytial viruses associated with acute respiratory infections in Thailand.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfluenza and respiratory syncytial virus (RSV) are significant contributors to acute respiratory infections and play a substantial role in seasonal morbidity. This study sought to elucidate the clinical characteristics, seasonal trends, and genetic evolution of circulating influenza and RSV strains in Thailand during the period from 2022 to 2023.
methodsNasopharyngeal swabs were obtained from 113 patients presenting with respiratory symptoms. Laboratory confirmation identified 57 cases of influenza and 25 cases of RSV infections. Clinical and demographic data were subjected to analysis. The hemagglutinin (HA) and attachment glycoprotein (G) genes from representative strains of influenza and RSV viruses were sequenced to facilitate phylogenetic and amino acid analyses.
resultsInfluenza cases were predominantly observed in younger adults aged 18–35 years, whereas RSV infections were distributed evenly across various age groups and were more prevalent among females. The clinical manifestations of influenza included cough, nasal congestion, sore throat, and myalgia. In contrast, RSV cases were associated with vomiting, pneumonia, bronchitis, and elevated rates of respiratory distress. The most prevalent influenza subtype was A/H3N2, accounting for 63.2% of cases, followed by A/H1N1 and B/Victoria. RSV-B was more prevalent than RSV-A, with a prevalence rate of 64.0%. The A/H3N2 strains exhibited divergence from the vaccine strain A/Darwin/9/2021, characterised by notable amino acid substitutions. Conversely, A/H1N1 strains remained closely aligned with the vaccine strains. The B/Victoria strains were categorised under the subclade V1A.3a.2 and consistently demonstrated a deletion of three amino acids in the HA gene. RSV-A isolates were identified as belonging to genotype ON1, while RSV-B isolates were classified under genotype BA9, both displaying characteristic duplications and substitutions.
conclusionThis study elucidates significant distinctions in the epidemiology and clinical outcomes of influenza and RSV in Thailand during 2022–2023. Influenza, particularly the A/H3N2 subtype, was more prevalent among younger adults and exhibited genetic divergence from the recommended vaccine strain, highlighting the necessity for continuous surveillance to inform vaccine updates. Conversely, RSV affected individuals across various age groups and was associated with more severe respiratory complications, with RSV-B being predominant. The genetic profiles of influenza and RSV strains, including amino acid substitutions and lineage-specific deletions or duplications, offer valuable insights into viral evolution and immune evasion. Collectively, these findings underscore the importance of integrated clinical and molecular surveillance to inform vaccine strain selection, enhance diagnostic accuracy, and bolster public health preparedness against seasonal respiratory pathogens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.